Medication info

Zentrol Tablets (Ezetimibe)

Prescription medicationTabletExpired
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Celix Co., Ltd.
Appearance
White to almost white oblong tablets
Packaging
- - 30 tablets/PTP [10 tablets/PTP × 3]
Approval status
Expired

MFDS item code 201903589 · Approved 2019.05.30

This product's status changed to Expired on 2024.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), treatment with this medicine should be initiated at the recommended starting dose of the HMG-CoA reductase inhibitor. In patients already receiving a high dose of an HMG-CoA reductase inhibitor, this medicine should be coadministered while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is coadministered with fenofibrate (in patients with mixed hyperlipidemia), it should be given with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in elderly patients No dosage adjustment is necessary when administering this medicine to elderly patients. Concomitant use with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Ingredients

Manufacturer
Celix Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • phytosterolemia
  • hypercholesterolemia
  • atherosclerotic vascular disease
  • dyslipidemia
  • diabetes
  • hypothyroidism
View approved original text

This drug is primarily used for the treatment of patients with primary hypercholesterolemia and mixed hyperlipidemia. It helps reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B, and can be administered alone or in combination with other lipid-lowering therapies alongside dietary management. Particularly, it may be used in conjunction with other treatments for patients with homozygous familial hypercholesterolemia. Additionally, it is used to lower plant sterol levels in patients with homozygous sitosterolemia and is indicated for patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. This drug helps manage lipid levels and reduce the risk of cardiovascular diseases. Therefore, it is used in the treatment of hypercholesterolemia and related dyslipidemias.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), treatment with this medicine should be initiated at the recommended starting dose of the HMG-CoA reductase inhibitor. In patients already receiving a high dose of an HMG-CoA reductase inhibitor, this medicine should be coadministered while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is coadministered with fenofibrate (in patients with mixed hyperlipidemia), it should be given with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in elderly patients No dosage adjustment is necessary when administering this medicine to elderly patients. Concomitant use with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Precautions

This drug should not be administered to patients with hypersensitivity to its components. Patients with active liver disease or persistently elevated liver enzyme levels in blood tests should avoid combination use of this drug with certain lipid-lowering agents. Caution is advised for pregnant or breastfeeding women as combination use of this drug with certain lipid-lowering agents is prohibited. Patients with severely impaired liver function or gallbladder disease, or severe kidney function impairment should refrain from using this drug in combination with certain fibrates. Patients with moderate to severe liver impairment should not use this drug, as it may increase exposure and lead to unexpected side effects. While this drug is generally well tolerated, side effects such as fatigue, abdominal pain, diarrhea, headache, and arthralgia may occur, and it is necessary to consult a doctor if any abnormal symptoms arise. Regular liver function tests are needed when taking this drug in conjunction with certain statins due to the risk of elevated liver enzyme levels. If symptoms such as myalgia or muscle weakness occur, medical personnel must be notified immediately, and in severe cases, drug administration may be discontinued. Patients with severely decreased kidney function also need caution when taking this drug, especially in combination with statins where dose adjustment and close monitoring are required. This drug may interact with other medications, so it's crucial to inform healthcare providers if cholestyramine, fibrates, cyclosporine, anticoagulants, etc. are being taken. There is insufficient safety data regarding its use during pregnancy, so pregnant women must consult a doctor before taking this drug. Breastfeeding women should consider stopping breastfeeding or using alternative medications, as this drug may be excreted in breast milk. It is not recommended for children under six years of age, and while its safety profile appears similar in pediatric or adolescent patients over six years, caution is necessary. Older adults can generally use this medication safely, but some sensitive reactions may occur, so observation is needed. Severe side effects from overdose are rare, but immediate medical help is required if any abnormal symptoms arise. This drug must be stored out of the reach of children and should not be transferred to other containers.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • joint pain
  • low back pain
  • cough
  • chest pain
Show 60 more
  • dizziness
  • headache
  • constipation
  • abdominal distension
  • nausea
  • elevated AST
  • elevated ALT
  • muscle pain
  • myopathy
  • rhabdomyolysis
  • increased liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • chest discomfort
  • breast discomfort
  • edema
  • weakness
  • generalized edema
  • diabetic neuropathy
  • tremor
  • epigastric pain
  • vomiting
  • gastritis
  • dry mouth
  • discomfort in the epigastrium
  • belching
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • runny nose
  • limb pain
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • excessive sweating
  • rash
  • itching
  • upper respiratory tract infection
  • conjunctival congestion
  • renal failure
  • liver function abnormalities
  • increased serum creatinine
  • hypertension
  • increased blood urea
  • increased serum creatine phosphokinase
  • abnormal liver function tests
  • dyspepsia
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly sealed container to avoid exposure to air and moisture. Additionally, the drug should be kept at room temperature between 1 degree and 30 degrees Celsius to maintain effectiveness.

Appearance and packaging

Appearance

White to almost white oblong tablets

Package unit

- - 30 tablets/PTP [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.